Subscribe to Newsletter
Subspecialties Comprehensive, Basic & Translational Research

Spicing Up Uveitis Treatment

Researchers at Texas A&M University in the USA have used turmeric – specifically, its principal compound, curcumin – to develop a therapeutic that decreased ocular inflammation in dogs suffering from uveitis.

Their novel formulation of curcumin has been shown to successfully bypass intestinal and ocular barriers, resulting in improved absorption of the medication. Current uveitis treatments have multiple unwanted side effects, including stomach ulcers, effects on kidney and liver function, and increasing diabetic patients’ glucose levels. Curcumin, in contrast, has no known side effects. According to Erin Scott, Assistant Professor at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences, the new therapeutic has great potential for treating uveitis in humans.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. R Ganugula et al., Science Advances 6, 35 (2020).
About the Author
Aleksandra Jones

Editor of The Ophthalmologist

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: